Belgium vs Netherlands: Estimated antiretroviral therapy coverage among people living with HIV
Belgium
89.0%
in 2024
Netherlands
89.0%
in 2024
Belgium rank
22nd
Netherlands rank
22nd
Estimated antiretroviral therapy coverage among people living with HIV over time
- Belgium
- Netherlands
How they compare
Belgium currently reports 89.0% against 89.0% in Netherlands, a difference of 0.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Netherlands ahead.
Belgium ranks 22nd and Netherlands ranks 22nd of 143 countries.
Across the 3 decades both report, Belgium averaged higher in 2 and Netherlands in 1.
Head to head by decade
| Decade | Belgium | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 54.8% | 53.5% | 1.3% | Belgium |
| 2010s | 81.6% | 77.1% | 4.5% | Belgium |
| 2020s | 87.0% | 87.8% | 0.8% | Netherlands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among people living with hiv, Belgium or Netherlands?
- Belgium, at 89.0% against 89.0% in Netherlands as of 2024.
- What is the difference in estimated antiretroviral therapy coverage among people living with hiv between Belgium and Netherlands?
- 0.0%, with Belgium ahead.
- How many years of comparable data are there for Belgium and Netherlands?
- 25 years are reported by both, from 2000 to 2024.
- How do Belgium and Netherlands rank globally for estimated antiretroviral therapy coverage among people living with hiv?
- Belgium ranks 22nd and Netherlands ranks 22nd of 143 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.